Tomoki Himiyama

Dr. Tomoki Himiyama

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 April 2019 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
THTomoki Himiyama
Tomoki Himiyama
MWMinoru Waki
Minoru Waki
YMYoshifumi Maegawa
Yoshifumi Maegawa
SIShinji Inagaki
Shinji Inagaki

16 November 2015 in ACS Catalysis
Verified
Journal Article
Closed access
Daniel SauerDaniel Sauer
Daniel Sauer
THTomoki Himiyama
Tomoki Himiyama
KTKengo Tachikawa
Kengo Tachikawa
KFKazuki Fukumoto
Kazuki Fukumoto
AOAkira Onoda
Akira Onoda
JOJun Okuda
Jun Okuda

1 May 2016 in Journal of Inorganic Biochemistry
Verified
Journal Article
Closed access
THTomoki Himiyama
Tomoki Himiyama
Daniel SauerDaniel Sauer
Daniel Sauer
AOAkira Onoda
Akira Onoda
TSThomas P. Spaniol
Thomas P. Spaniol
Jun OkudaJun Okuda
Jun Okuda
THTakashi Hayashi
Takashi Hayashi

24 June 2016 in Beilstein Journal of Organic Chemistry
Verified
Journal Article
Open access
PDF file
HOHassan Osseili
Hassan Osseili
Daniel SauerDaniel Sauer
Daniel Sauer
KBKlaus Beckerle
Klaus Beckerle
MAMarcus Arlt
Marcus Arlt
THTomoki Himiyama
Tomoki Himiyama
Jun OkudaJun Okuda
Jun Okuda
Copper(I) and copper(II) complexes were covalently linked to an engineered variant of the transmembrane protein Ferric hydroxamate uptake protein component A (FhuA ΔCVFtev). Copper(I) was incorporated using an N-heterocyclic carbene (NHC) ligand equipped with a maleimide group on the side arm at the imidazole nitrogen. Copper(II) was attached by coordination to a terpyridyl ligand. The spacer length was varied in the back of the ligand framework. These biohybrid catalysts were shown to be active in the Diels–Alder reaction of a chalcone derivative with cyclopentadiene to preferentially give the endo product.

9 August 2017 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
THTomoki Himiyama
Tomoki Himiyama
NTNaomasa Taniguchi
Naomasa Taniguchi
SKShunsuke Kato
Shunsuke Kato
AOAkira Onoda
Akira Onoda
THTakashi Hayashi
Takashi Hayashi

4 July 2024 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
YKYoshiyuki Kagawa
Yoshiyuki Kagawa
KOKoji Oohora
Koji Oohora
THTomoki Himiyama
Tomoki Himiyama
ASAkihiro Suzuki
Akihiro Suzuki
THTakashi Hayashi
Takashi Hayashi
Design of metal cofactor ligands is essential for controlling the reactivity of metalloenzymes. We investigated a carbene transfer reaction catalyzed by myoglobins containing iron porphyrin cofactors with one and two trifluoromethyl groups at peripheral sites (FePorCF3 and FePor(CF3)2, respectively), native heme and iron porphycene (FePc). These four myoglobins show a wide range of Fe(II)/Fe(III) redox potentials in the protein of +147 mV, +87 mV, +42 mV and −198 mV vs. NHE, respectively. Myoglobin reconstituted with FePor(CF3)2 has a more positive potential, which enhances the reactivity of a carbene intermediate with alkenes, and demonstrates superior cyclopropanation of inert alkenes, such as aliphatic and internal alkenes. In contrast, engineered myoglobin reconstituted with FePc has a more negative redox potential, which accelerates the formation of the intermediate, but has low reactivity for inert alkenes. Mechanistic studies indicate that myoglobin with FePor(CF3)2 generates an undetectable active intermediate with a radical character. In contrast, this reaction catalyzed by myoglobin with FePc includes a detectable iron–carbene species with electrophilic character. This finding highlights the importance of redox‐focused design of the iron porphyrinoid cofactor in hemoproteins to tune the reactivity of the carbene transfer reaction.